The future of psoriasis and psoriatic arthritis management extends beyond new therapies. It is increasingly driven by biomarker-guided treatment, AI-enabled clinical decision support, precision dermatology, and digital health technologies.
Our latest case study explores how leading Key Opinion Leaders view these emerging trends and what they mean for pharmaceutical companies, healthcare providers, and MedTech innovators.
Read the complete case study:
https://www.sperresearch.com/Case-Studies/psoriasis-psoriatic-arthritis-kol-insights
Top comments (0)